nodes	percent_of_prediction	percent_of_DWPC	metapath
Succinylcholine—CHRM3—epilepsy syndrome	0.185	0.3	CbGaD
Succinylcholine—CHRM1—epilepsy syndrome	0.173	0.28	CbGaD
Succinylcholine—CHRM2—epilepsy syndrome	0.141	0.229	CbGaD
Succinylcholine—BCHE—epilepsy syndrome	0.118	0.191	CbGaD
Succinylcholine—CHRNA10—ear—epilepsy syndrome	0.0078	0.188	CbGeAlD
Succinylcholine—CHRNG—tongue—epilepsy syndrome	0.00566	0.137	CbGeAlD
Succinylcholine—CHRNA1—tongue—epilepsy syndrome	0.00375	0.0905	CbGeAlD
Succinylcholine—CHRNG—medulla oblongata—epilepsy syndrome	0.00173	0.0419	CbGeAlD
Succinylcholine—Carbachol—CHRNA2—epilepsy syndrome	0.00166	0.243	CrCbGaD
Succinylcholine—CHRNG—midbrain—epilepsy syndrome	0.00158	0.0383	CbGeAlD
Succinylcholine—CHRNG—head—epilepsy syndrome	0.00137	0.0332	CbGeAlD
Succinylcholine—Decamethonium—CHRNA2—epilepsy syndrome	0.00126	0.184	CrCbGaD
Succinylcholine—CHRNA10—head—epilepsy syndrome	0.00117	0.0281	CbGeAlD
Succinylcholine—Decamethonium—HRH3—epilepsy syndrome	0.000985	0.144	CrCbGaD
Succinylcholine—CHRNA1—head—epilepsy syndrome	0.00091	0.022	CbGeAlD
Succinylcholine—CHRNB1—medulla oblongata—epilepsy syndrome	0.000886	0.0214	CbGeAlD
Succinylcholine—CHRNB1—midbrain—epilepsy syndrome	0.00081	0.0196	CbGeAlD
Succinylcholine—CHRNB1—spinal cord—epilepsy syndrome	0.00079	0.0191	CbGeAlD
Succinylcholine—CHRM2—forebrain—epilepsy syndrome	0.000786	0.019	CbGeAlD
Succinylcholine—Carbachol—CHRM3—epilepsy syndrome	0.000779	0.114	CrCbGaD
Succinylcholine—Carbachol—CHRM1—epilepsy syndrome	0.000726	0.106	CrCbGaD
Succinylcholine—CHRM2—telencephalon—epilepsy syndrome	0.000723	0.0175	CbGeAlD
Succinylcholine—CHRM1—forebrain—epilepsy syndrome	0.000716	0.0173	CbGeAlD
Succinylcholine—CHRNB1—head—epilepsy syndrome	0.000702	0.017	CbGeAlD
Succinylcholine—CHRNA1—brain—epilepsy syndrome	0.000659	0.0159	CbGeAlD
Succinylcholine—CHRM1—telencephalon—epilepsy syndrome	0.000658	0.0159	CbGeAlD
Succinylcholine—CHRM3—forebrain—epilepsy syndrome	0.000641	0.0155	CbGeAlD
Succinylcholine—CHRNB1—cerebellum—epilepsy syndrome	0.000627	0.0151	CbGeAlD
Succinylcholine—Carbachol—CHRM2—epilepsy syndrome	0.000593	0.0869	CrCbGaD
Succinylcholine—CHRM3—telencephalon—epilepsy syndrome	0.000589	0.0142	CbGeAlD
Succinylcholine—BCHE—brainstem—epilepsy syndrome	0.000542	0.0131	CbGeAlD
Succinylcholine—BCHE—forebrain—epilepsy syndrome	0.000523	0.0126	CbGeAlD
Succinylcholine—CHRNB1—brain—epilepsy syndrome	0.000509	0.0123	CbGeAlD
Succinylcholine—BCHE—telencephalon—epilepsy syndrome	0.000481	0.0116	CbGeAlD
Succinylcholine—CHRM2—head—epilepsy syndrome	0.00045	0.0109	CbGeAlD
Succinylcholine—Decamethonium—CHRM2—epilepsy syndrome	0.000449	0.0659	CrCbGaD
Succinylcholine—CHRM2—nervous system—epilepsy syndrome	0.000427	0.0103	CbGeAlD
Succinylcholine—CHRM2—central nervous system—epilepsy syndrome	0.000411	0.00992	CbGeAlD
Succinylcholine—CHRM1—head—epilepsy syndrome	0.00041	0.00989	CbGeAlD
Succinylcholine—CHRM1—nervous system—epilepsy syndrome	0.000389	0.00938	CbGeAlD
Succinylcholine—BCHE—medulla oblongata—epilepsy syndrome	0.000378	0.00912	CbGeAlD
Succinylcholine—Decamethonium—BCHE—epilepsy syndrome	0.000375	0.0549	CrCbGaD
Succinylcholine—CHRM1—central nervous system—epilepsy syndrome	0.000374	0.00903	CbGeAlD
Succinylcholine—Bronchospasm—Lamotrigine—epilepsy syndrome	0.000369	0.00231	CcSEcCtD
Succinylcholine—CHRM3—head—epilepsy syndrome	0.000367	0.00885	CbGeAlD
Succinylcholine—Bradycardia—Diazepam—epilepsy syndrome	0.000366	0.00229	CcSEcCtD
Succinylcholine—Hypotension—Phenobarbital—epilepsy syndrome	0.00036	0.00225	CcSEcCtD
Succinylcholine—Myalgia—Clobazam—epilepsy syndrome	0.000359	0.00225	CcSEcCtD
Succinylcholine—Arrhythmia—Propofol—epilepsy syndrome	0.000359	0.00225	CcSEcCtD
Succinylcholine—Renal failure—Phenytoin—epilepsy syndrome	0.000357	0.00224	CcSEcCtD
Succinylcholine—Renal failure—Oxcarbazepine—epilepsy syndrome	0.000355	0.00222	CcSEcCtD
Succinylcholine—Bradycardia—Felbamate—epilepsy syndrome	0.000354	0.00222	CcSEcCtD
Succinylcholine—Pulmonary oedema—Gabapentin—epilepsy syndrome	0.000351	0.0022	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Phenobarbital—epilepsy syndrome	0.000351	0.0022	CcSEcCtD
Succinylcholine—Shock—Lacosamide—epilepsy syndrome	0.000349	0.00219	CcSEcCtD
Succinylcholine—CHRM3—nervous system—epilepsy syndrome	0.000348	0.00839	CbGeAlD
Succinylcholine—Bradycardia—Zonisamide—epilepsy syndrome	0.000346	0.00217	CcSEcCtD
Succinylcholine—Hypertonia—Gabapentin—epilepsy syndrome	0.000346	0.00217	CcSEcCtD
Succinylcholine—BCHE—midbrain—epilepsy syndrome	0.000345	0.00833	CbGeAlD
Succinylcholine—Renal failure—Carbamazepine—epilepsy syndrome	0.00034	0.00213	CcSEcCtD
Succinylcholine—Renal failure acute—Pregabalin—epilepsy syndrome	0.000338	0.00212	CcSEcCtD
Succinylcholine—BCHE—spinal cord—epilepsy syndrome	0.000337	0.00813	CbGeAlD
Succinylcholine—CHRM3—central nervous system—epilepsy syndrome	0.000335	0.00808	CbGeAlD
Succinylcholine—Bradycardia—Phenytoin—epilepsy syndrome	0.000332	0.00208	CcSEcCtD
Succinylcholine—Bradycardia—Oxcarbazepine—epilepsy syndrome	0.00033	0.00207	CcSEcCtD
Succinylcholine—Renal failure—Lamotrigine—epilepsy syndrome	0.000329	0.00206	CcSEcCtD
Succinylcholine—CHRM2—brain—epilepsy syndrome	0.000326	0.00788	CbGeAlD
Succinylcholine—Rash—Amobarbital—epilepsy syndrome	0.000323	0.00203	CcSEcCtD
Succinylcholine—Dermatitis—Amobarbital—epilepsy syndrome	0.000323	0.00203	CcSEcCtD
Succinylcholine—Flushing—Felbamate—epilepsy syndrome	0.000323	0.00202	CcSEcCtD
Succinylcholine—Anaphylactoid reaction—Pregabalin—epilepsy syndrome	0.000322	0.00202	CcSEcCtD
Succinylcholine—Salivary hypersecretion—Topiramate—epilepsy syndrome	0.000322	0.00202	CcSEcCtD
Succinylcholine—Hypotension—Clobazam—epilepsy syndrome	0.000322	0.00202	CcSEcCtD
Succinylcholine—Arrhythmia—Diazepam—epilepsy syndrome	0.000321	0.00201	CcSEcCtD
Succinylcholine—Bradycardia—Carbamazepine—epilepsy syndrome	0.000317	0.00198	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Clobazam—epilepsy syndrome	0.000314	0.00197	CcSEcCtD
Succinylcholine—Rash—Primidone—epilepsy syndrome	0.000312	0.00195	CcSEcCtD
Succinylcholine—Dermatitis—Primidone—epilepsy syndrome	0.000311	0.00195	CcSEcCtD
Succinylcholine—Renal failure acute—Gabapentin—epilepsy syndrome	0.00031	0.00194	CcSEcCtD
Succinylcholine—Anaphylactic shock—Acetazolamide—epilepsy syndrome	0.000307	0.00192	CcSEcCtD
Succinylcholine—Urticaria—Phenobarbital—epilepsy syndrome	0.000306	0.00192	CcSEcCtD
Succinylcholine—Body temperature increased—Phenobarbital—epilepsy syndrome	0.000304	0.00191	CcSEcCtD
Succinylcholine—Flushing—Clonazepam—epilepsy syndrome	0.000304	0.00191	CcSEcCtD
Succinylcholine—Shock—Acetazolamide—epilepsy syndrome	0.000302	0.00189	CcSEcCtD
Succinylcholine—Hypertension—Propofol—epilepsy syndrome	0.000302	0.00189	CcSEcCtD
Succinylcholine—Flushing—Oxcarbazepine—epilepsy syndrome	0.000301	0.00188	CcSEcCtD
Succinylcholine—BCHE—head—epilepsy syndrome	0.000299	0.00723	CbGeAlD
Succinylcholine—Myalgia—Propofol—epilepsy syndrome	0.000297	0.00186	CcSEcCtD
Succinylcholine—CHRM1—brain—epilepsy syndrome	0.000297	0.00717	CbGeAlD
Succinylcholine—Cardiac arrest—Pregabalin—epilepsy syndrome	0.000297	0.00186	CcSEcCtD
Succinylcholine—Hypertonia—Topiramate—epilepsy syndrome	0.000291	0.00182	CcSEcCtD
Succinylcholine—Arrhythmia—Oxcarbazepine—epilepsy syndrome	0.000289	0.00181	CcSEcCtD
Succinylcholine—Flushing—Carbamazepine—epilepsy syndrome	0.000289	0.00181	CcSEcCtD
Succinylcholine—Myalgia—Levetiracetam—epilepsy syndrome	0.000287	0.0018	CcSEcCtD
Succinylcholine—Anaphylactic shock—Propofol—epilepsy syndrome	0.000285	0.00179	CcSEcCtD
Succinylcholine—BCHE—nervous system—epilepsy syndrome	0.000284	0.00685	CbGeAlD
Succinylcholine—Hypersensitivity—Phenobarbital—epilepsy syndrome	0.000284	0.00178	CcSEcCtD
Succinylcholine—Urticaria—Lacosamide—epilepsy syndrome	0.000282	0.00177	CcSEcCtD
Succinylcholine—Hypertension—Fosphenytoin—epilepsy syndrome	0.000281	0.00176	CcSEcCtD
Succinylcholine—Body temperature increased—Lacosamide—epilepsy syndrome	0.000281	0.00176	CcSEcCtD
Succinylcholine—Shock—Propofol—epilepsy syndrome	0.000281	0.00176	CcSEcCtD
Succinylcholine—Anaphylactic shock—Midazolam—epilepsy syndrome	0.000279	0.00175	CcSEcCtD
Succinylcholine—Flushing—Lamotrigine—epilepsy syndrome	0.000279	0.00175	CcSEcCtD
Succinylcholine—Hypersensitivity—Rufinamide—epilepsy syndrome	0.000278	0.00175	CcSEcCtD
Succinylcholine—Tachycardia—Propofol—epilepsy syndrome	0.000278	0.00174	CcSEcCtD
Succinylcholine—Arrhythmia—Carbamazepine—epilepsy syndrome	0.000278	0.00174	CcSEcCtD
Succinylcholine—Myalgia—Fosphenytoin—epilepsy syndrome	0.000277	0.00174	CcSEcCtD
Succinylcholine—Shock—Midazolam—epilepsy syndrome	0.000274	0.00172	CcSEcCtD
Succinylcholine—Rash—Trimethadione—epilepsy syndrome	0.000274	0.00172	CcSEcCtD
Succinylcholine—Dermatitis—Trimethadione—epilepsy syndrome	0.000274	0.00172	CcSEcCtD
Succinylcholine—Urticaria—Clobazam—epilepsy syndrome	0.000274	0.00171	CcSEcCtD
Succinylcholine—BCHE—central nervous system—epilepsy syndrome	0.000273	0.0066	CbGeAlD
Succinylcholine—Body temperature increased—Clobazam—epilepsy syndrome	0.000272	0.00171	CcSEcCtD
Succinylcholine—Tachycardia—Midazolam—epilepsy syndrome	0.000272	0.00171	CcSEcCtD
Succinylcholine—Cardiac arrest—Gabapentin—epilepsy syndrome	0.000272	0.0017	CcSEcCtD
Succinylcholine—Myalgia—Vigabatrin—epilepsy syndrome	0.00027	0.00169	CcSEcCtD
Succinylcholine—BCHE—cerebellum—epilepsy syndrome	0.000267	0.00645	CbGeAlD
Succinylcholine—Hypotension—Propofol—epilepsy syndrome	0.000266	0.00167	CcSEcCtD
Succinylcholine—Myalgia—Diazepam—epilepsy syndrome	0.000266	0.00167	CcSEcCtD
Succinylcholine—Anaphylactic shock—Fosphenytoin—epilepsy syndrome	0.000266	0.00167	CcSEcCtD
Succinylcholine—CHRM3—brain—epilepsy syndrome	0.000266	0.00642	CbGeAlD
Succinylcholine—Shock—Fosphenytoin—epilepsy syndrome	0.000262	0.00164	CcSEcCtD
Succinylcholine—Hypersensitivity—Lacosamide—epilepsy syndrome	0.000261	0.00164	CcSEcCtD
Succinylcholine—Hypertension—Felbamate—epilepsy syndrome	0.000261	0.00164	CcSEcCtD
Succinylcholine—Hypotension—Midazolam—epilepsy syndrome	0.000261	0.00163	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Propofol—epilepsy syndrome	0.00026	0.00163	CcSEcCtD
Succinylcholine—Tachycardia—Fosphenytoin—epilepsy syndrome	0.00026	0.00163	CcSEcCtD
Succinylcholine—Myalgia—Felbamate—epilepsy syndrome	0.000258	0.00161	CcSEcCtD
Succinylcholine—Hypertension—Zonisamide—epilepsy syndrome	0.000256	0.0016	CcSEcCtD
Succinylcholine—Anaphylactic shock—Diazepam—epilepsy syndrome	0.000255	0.0016	CcSEcCtD
Succinylcholine—Myalgia—Zonisamide—epilepsy syndrome	0.000252	0.00158	CcSEcCtD
Succinylcholine—Shock—Diazepam—epilepsy syndrome	0.000251	0.00157	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Levetiracetam—epilepsy syndrome	0.000251	0.00157	CcSEcCtD
Succinylcholine—Tachycardia—Diazepam—epilepsy syndrome	0.000249	0.00156	CcSEcCtD
Succinylcholine—Hypotension—Fosphenytoin—epilepsy syndrome	0.000248	0.00156	CcSEcCtD
Succinylcholine—Anaphylactic shock—Felbamate—epilepsy syndrome	0.000247	0.00155	CcSEcCtD
Succinylcholine—Hypertension—Phenytoin—epilepsy syndrome	0.000245	0.00153	CcSEcCtD
Succinylcholine—Urticaria—Acetazolamide—epilepsy syndrome	0.000244	0.00153	CcSEcCtD
Succinylcholine—Hypertension—Oxcarbazepine—epilepsy syndrome	0.000244	0.00153	CcSEcCtD
Succinylcholine—Bronchospasm—Gabapentin—epilepsy syndrome	0.000243	0.00152	CcSEcCtD
Succinylcholine—Bradycardia—Valproic Acid—epilepsy syndrome	0.000243	0.00152	CcSEcCtD
Succinylcholine—Myalgia—Clonazepam—epilepsy syndrome	0.000243	0.00152	CcSEcCtD
Succinylcholine—Rash—Phenobarbital—epilepsy syndrome	0.000243	0.00152	CcSEcCtD
Succinylcholine—Body temperature increased—Acetazolamide—epilepsy syndrome	0.000243	0.00152	CcSEcCtD
Succinylcholine—Dermatitis—Phenobarbital—epilepsy syndrome	0.000243	0.00152	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Fosphenytoin—epilepsy syndrome	0.000242	0.00152	CcSEcCtD
Succinylcholine—Myalgia—Phenytoin—epilepsy syndrome	0.000241	0.00151	CcSEcCtD
Succinylcholine—Tachycardia—Felbamate—epilepsy syndrome	0.000241	0.00151	CcSEcCtD
Succinylcholine—Myalgia—Oxcarbazepine—epilepsy syndrome	0.00024	0.0015	CcSEcCtD
Succinylcholine—Hypotension—Diazepam—epilepsy syndrome	0.000238	0.00149	CcSEcCtD
Succinylcholine—Rash—Rufinamide—epilepsy syndrome	0.000238	0.00149	CcSEcCtD
Succinylcholine—Dermatitis—Rufinamide—epilepsy syndrome	0.000238	0.00149	CcSEcCtD
Succinylcholine—Shock—Zonisamide—epilepsy syndrome	0.000238	0.00149	CcSEcCtD
Succinylcholine—Renal failure—Pregabalin—epilepsy syndrome	0.000236	0.00148	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Vigabatrin—epilepsy syndrome	0.000236	0.00148	CcSEcCtD
Succinylcholine—Tachycardia—Zonisamide—epilepsy syndrome	0.000236	0.00148	CcSEcCtD
Succinylcholine—Hypertension—Carbamazepine—epilepsy syndrome	0.000234	0.00146	CcSEcCtD
Succinylcholine—Anaphylactic shock—Clonazepam—epilepsy syndrome	0.000233	0.00146	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Diazepam—epilepsy syndrome	0.000232	0.00146	CcSEcCtD
Succinylcholine—Anaphylactic shock—Phenytoin—epilepsy syndrome	0.000231	0.00145	CcSEcCtD
Succinylcholine—Hypotension—Felbamate—epilepsy syndrome	0.000231	0.00145	CcSEcCtD
Succinylcholine—Myalgia—Carbamazepine—epilepsy syndrome	0.00023	0.00144	CcSEcCtD
Succinylcholine—Anaphylactic shock—Oxcarbazepine—epilepsy syndrome	0.00023	0.00144	CcSEcCtD
Succinylcholine—Shock—Phenytoin—epilepsy syndrome	0.000228	0.00143	CcSEcCtD
Succinylcholine—Tachycardia—Clonazepam—epilepsy syndrome	0.000227	0.00142	CcSEcCtD
Succinylcholine—Urticaria—Propofol—epilepsy syndrome	0.000227	0.00142	CcSEcCtD
Succinylcholine—Shock—Oxcarbazepine—epilepsy syndrome	0.000226	0.00142	CcSEcCtD
Succinylcholine—Hypotension—Zonisamide—epilepsy syndrome	0.000226	0.00142	CcSEcCtD
Succinylcholine—Tachycardia—Phenytoin—epilepsy syndrome	0.000226	0.00142	CcSEcCtD
Succinylcholine—Hypertension—Lamotrigine—epilepsy syndrome	0.000226	0.00142	CcSEcCtD
Succinylcholine—Body temperature increased—Propofol—epilepsy syndrome	0.000225	0.00141	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Felbamate—epilepsy syndrome	0.000225	0.00141	CcSEcCtD
Succinylcholine—Tachycardia—Oxcarbazepine—epilepsy syndrome	0.000225	0.00141	CcSEcCtD
Succinylcholine—Rash—Lacosamide—epilepsy syndrome	0.000224	0.0014	CcSEcCtD
Succinylcholine—Dermatitis—Lacosamide—epilepsy syndrome	0.000224	0.0014	CcSEcCtD
Succinylcholine—Myalgia—Lamotrigine—epilepsy syndrome	0.000223	0.0014	CcSEcCtD
Succinylcholine—Urticaria—Midazolam—epilepsy syndrome	0.000222	0.00139	CcSEcCtD
Succinylcholine—Anaphylactic shock—Carbamazepine—epilepsy syndrome	0.000221	0.00138	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Zonisamide—epilepsy syndrome	0.00022	0.00138	CcSEcCtD
Succinylcholine—Bradycardia—Pregabalin—epilepsy syndrome	0.00022	0.00138	CcSEcCtD
Succinylcholine—Body temperature increased—Levetiracetam—epilepsy syndrome	0.000218	0.00136	CcSEcCtD
Succinylcholine—Hypotension—Clonazepam—epilepsy syndrome	0.000218	0.00136	CcSEcCtD
Succinylcholine—Shock—Carbamazepine—epilepsy syndrome	0.000217	0.00136	CcSEcCtD
Succinylcholine—Rash—Clobazam—epilepsy syndrome	0.000217	0.00136	CcSEcCtD
Succinylcholine—Dermatitis—Clobazam—epilepsy syndrome	0.000217	0.00136	CcSEcCtD
Succinylcholine—BCHE—brain—epilepsy syndrome	0.000217	0.00524	CbGeAlD
Succinylcholine—Renal failure—Gabapentin—epilepsy syndrome	0.000217	0.00136	CcSEcCtD
Succinylcholine—Hypotension—Phenytoin—epilepsy syndrome	0.000216	0.00136	CcSEcCtD
Succinylcholine—Tachycardia—Carbamazepine—epilepsy syndrome	0.000216	0.00135	CcSEcCtD
Succinylcholine—Hypotension—Oxcarbazepine—epilepsy syndrome	0.000215	0.00135	CcSEcCtD
Succinylcholine—Arrhythmia—Valproic Acid—epilepsy syndrome	0.000213	0.00134	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Clonazepam—epilepsy syndrome	0.000212	0.00133	CcSEcCtD
Succinylcholine—Urticaria—Fosphenytoin—epilepsy syndrome	0.000211	0.00132	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Phenytoin—epilepsy syndrome	0.000211	0.00132	CcSEcCtD
Succinylcholine—Body temperature increased—Fosphenytoin—epilepsy syndrome	0.00021	0.00132	CcSEcCtD
Succinylcholine—Shock—Lamotrigine—epilepsy syndrome	0.00021	0.00132	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Oxcarbazepine—epilepsy syndrome	0.00021	0.00131	CcSEcCtD
Succinylcholine—Tachycardia—Lamotrigine—epilepsy syndrome	0.000208	0.00131	CcSEcCtD
Succinylcholine—Hypotension—Carbamazepine—epilepsy syndrome	0.000206	0.00129	CcSEcCtD
Succinylcholine—Urticaria—Vigabatrin—epilepsy syndrome	0.000206	0.00129	CcSEcCtD
Succinylcholine—Hypersensitivity—Midazolam—epilepsy syndrome	0.000206	0.00129	CcSEcCtD
Succinylcholine—Body temperature increased—Vigabatrin—epilepsy syndrome	0.000205	0.00128	CcSEcCtD
Succinylcholine—Hypersensitivity—Levetiracetam—epilepsy syndrome	0.000203	0.00127	CcSEcCtD
Succinylcholine—Urticaria—Diazepam—epilepsy syndrome	0.000203	0.00127	CcSEcCtD
Succinylcholine—Bradycardia—Gabapentin—epilepsy syndrome	0.000202	0.00126	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Carbamazepine—epilepsy syndrome	0.000201	0.00126	CcSEcCtD
Succinylcholine—Flushing—Pregabalin—epilepsy syndrome	0.0002	0.00126	CcSEcCtD
Succinylcholine—Urticaria—Felbamate—epilepsy syndrome	0.000196	0.00123	CcSEcCtD
Succinylcholine—Body temperature increased—Felbamate—epilepsy syndrome	0.000195	0.00122	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Lamotrigine—epilepsy syndrome	0.000195	0.00122	CcSEcCtD
Succinylcholine—Arrhythmia—Pregabalin—epilepsy syndrome	0.000193	0.00121	CcSEcCtD
Succinylcholine—Urticaria—Zonisamide—epilepsy syndrome	0.000192	0.0012	CcSEcCtD
Succinylcholine—Body temperature increased—Zonisamide—epilepsy syndrome	0.000191	0.0012	CcSEcCtD
Succinylcholine—Hypersensitivity—Vigabatrin—epilepsy syndrome	0.000191	0.0012	CcSEcCtD
Succinylcholine—Hypersensitivity—Diazepam—epilepsy syndrome	0.000188	0.00118	CcSEcCtD
Succinylcholine—Urticaria—Clonazepam—epilepsy syndrome	0.000185	0.00116	CcSEcCtD
Succinylcholine—Body temperature increased—Clonazepam—epilepsy syndrome	0.000184	0.00115	CcSEcCtD
Succinylcholine—Urticaria—Phenytoin—epilepsy syndrome	0.000184	0.00115	CcSEcCtD
Succinylcholine—Body temperature increased—Phenytoin—epilepsy syndrome	0.000183	0.00115	CcSEcCtD
Succinylcholine—Urticaria—Oxcarbazepine—epilepsy syndrome	0.000183	0.00115	CcSEcCtD
Succinylcholine—Renal failure—Topiramate—epilepsy syndrome	0.000182	0.00114	CcSEcCtD
Succinylcholine—Body temperature increased—Oxcarbazepine—epilepsy syndrome	0.000182	0.00114	CcSEcCtD
Succinylcholine—Rash—Propofol—epilepsy syndrome	0.00018	0.00113	CcSEcCtD
Succinylcholine—Dermatitis—Propofol—epilepsy syndrome	0.00018	0.00113	CcSEcCtD
Succinylcholine—Hypertension—Valproic Acid—epilepsy syndrome	0.000179	0.00112	CcSEcCtD
Succinylcholine—Hypersensitivity—Zonisamide—epilepsy syndrome	0.000178	0.00112	CcSEcCtD
Succinylcholine—Myalgia—Valproic Acid—epilepsy syndrome	0.000177	0.00111	CcSEcCtD
Succinylcholine—Rash—Midazolam—epilepsy syndrome	0.000176	0.0011	CcSEcCtD
Succinylcholine—Dermatitis—Midazolam—epilepsy syndrome	0.000176	0.0011	CcSEcCtD
Succinylcholine—Urticaria—Carbamazepine—epilepsy syndrome	0.000175	0.0011	CcSEcCtD
Succinylcholine—Body temperature increased—Carbamazepine—epilepsy syndrome	0.000175	0.00109	CcSEcCtD
Succinylcholine—Rash—Levetiracetam—epilepsy syndrome	0.000174	0.00109	CcSEcCtD
Succinylcholine—Dermatitis—Levetiracetam—epilepsy syndrome	0.000174	0.00109	CcSEcCtD
Succinylcholine—Hypersensitivity—Clonazepam—epilepsy syndrome	0.000172	0.00108	CcSEcCtD
Succinylcholine—Hypersensitivity—Phenytoin—epilepsy syndrome	0.00017	0.00107	CcSEcCtD
Succinylcholine—Anaphylactic shock—Valproic Acid—epilepsy syndrome	0.00017	0.00106	CcSEcCtD
Succinylcholine—Urticaria—Lamotrigine—epilepsy syndrome	0.00017	0.00106	CcSEcCtD
Succinylcholine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	0.00017	0.00106	CcSEcCtD
Succinylcholine—Bradycardia—Topiramate—epilepsy syndrome	0.00017	0.00106	CcSEcCtD
Succinylcholine—Body temperature increased—Lamotrigine—epilepsy syndrome	0.000169	0.00106	CcSEcCtD
Succinylcholine—Rash—Fosphenytoin—epilepsy syndrome	0.000168	0.00105	CcSEcCtD
Succinylcholine—Dermatitis—Fosphenytoin—epilepsy syndrome	0.000167	0.00105	CcSEcCtD
Succinylcholine—Tachycardia—Valproic Acid—epilepsy syndrome	0.000166	0.00104	CcSEcCtD
Succinylcholine—Rash—Vigabatrin—epilepsy syndrome	0.000163	0.00102	CcSEcCtD
Succinylcholine—Dermatitis—Vigabatrin—epilepsy syndrome	0.000163	0.00102	CcSEcCtD
Succinylcholine—Hypersensitivity—Carbamazepine—epilepsy syndrome	0.000163	0.00102	CcSEcCtD
Succinylcholine—Hypertension—Pregabalin—epilepsy syndrome	0.000162	0.00102	CcSEcCtD
Succinylcholine—Rash—Diazepam—epilepsy syndrome	0.000161	0.00101	CcSEcCtD
Succinylcholine—Dermatitis—Diazepam—epilepsy syndrome	0.000161	0.00101	CcSEcCtD
Succinylcholine—Myalgia—Pregabalin—epilepsy syndrome	0.00016	0.001	CcSEcCtD
Succinylcholine—Hypotension—Valproic Acid—epilepsy syndrome	0.000159	0.000993	CcSEcCtD
Succinylcholine—Hypersensitivity—Lamotrigine—epilepsy syndrome	0.000157	0.000986	CcSEcCtD
Succinylcholine—Rash—Felbamate—epilepsy syndrome	0.000156	0.000976	CcSEcCtD
Succinylcholine—Dermatitis—Felbamate—epilepsy syndrome	0.000156	0.000975	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	0.000155	0.000969	CcSEcCtD
Succinylcholine—Flushing—Topiramate—epilepsy syndrome	0.000155	0.000969	CcSEcCtD
Succinylcholine—Anaphylactic shock—Pregabalin—epilepsy syndrome	0.000153	0.000961	CcSEcCtD
Succinylcholine—Rash—Zonisamide—epilepsy syndrome	0.000152	0.000955	CcSEcCtD
Succinylcholine—Dermatitis—Zonisamide—epilepsy syndrome	0.000152	0.000954	CcSEcCtD
Succinylcholine—Shock—Pregabalin—epilepsy syndrome	0.000151	0.000946	CcSEcCtD
Succinylcholine—Tachycardia—Pregabalin—epilepsy syndrome	0.00015	0.000938	CcSEcCtD
Succinylcholine—Hypertension—Gabapentin—epilepsy syndrome	0.000149	0.000932	CcSEcCtD
Succinylcholine—Rash—Clonazepam—epilepsy syndrome	0.000147	0.000921	CcSEcCtD
Succinylcholine—Dermatitis—Clonazepam—epilepsy syndrome	0.000147	0.00092	CcSEcCtD
Succinylcholine—Myalgia—Gabapentin—epilepsy syndrome	0.000147	0.000919	CcSEcCtD
Succinylcholine—Rash—Phenytoin—epilepsy syndrome	0.000146	0.000914	CcSEcCtD
Succinylcholine—Dermatitis—Phenytoin—epilepsy syndrome	0.000146	0.000914	CcSEcCtD
Succinylcholine—Rash—Oxcarbazepine—epilepsy syndrome	0.000145	0.00091	CcSEcCtD
Succinylcholine—Dermatitis—Oxcarbazepine—epilepsy syndrome	0.000145	0.000909	CcSEcCtD
Succinylcholine—Hypotension—Pregabalin—epilepsy syndrome	0.000143	0.000898	CcSEcCtD
Succinylcholine—Anaphylactic shock—Gabapentin—epilepsy syndrome	0.000141	0.000881	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	0.00014	0.000876	CcSEcCtD
Succinylcholine—Rash—Carbamazepine—epilepsy syndrome	0.000139	0.000873	CcSEcCtD
Succinylcholine—Dermatitis—Carbamazepine—epilepsy syndrome	0.000139	0.000872	CcSEcCtD
Succinylcholine—Shock—Gabapentin—epilepsy syndrome	0.000138	0.000867	CcSEcCtD
Succinylcholine—Tachycardia—Gabapentin—epilepsy syndrome	0.000137	0.00086	CcSEcCtD
Succinylcholine—Urticaria—Valproic Acid—epilepsy syndrome	0.000135	0.000845	CcSEcCtD
Succinylcholine—Rash—Lamotrigine—epilepsy syndrome	0.000135	0.000844	CcSEcCtD
Succinylcholine—Dermatitis—Lamotrigine—epilepsy syndrome	0.000134	0.000843	CcSEcCtD
Succinylcholine—Body temperature increased—Valproic Acid—epilepsy syndrome	0.000134	0.00084	CcSEcCtD
Succinylcholine—Hypotension—Gabapentin—epilepsy syndrome	0.000131	0.000823	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	0.000128	0.000803	CcSEcCtD
Succinylcholine—Hypertension—Topiramate—epilepsy syndrome	0.000125	0.000784	CcSEcCtD
Succinylcholine—Hypersensitivity—Valproic Acid—epilepsy syndrome	0.000125	0.000783	CcSEcCtD
Succinylcholine—Myalgia—Topiramate—epilepsy syndrome	0.000123	0.000773	CcSEcCtD
Succinylcholine—Urticaria—Pregabalin—epilepsy syndrome	0.000122	0.000763	CcSEcCtD
Succinylcholine—Body temperature increased—Pregabalin—epilepsy syndrome	0.000121	0.00076	CcSEcCtD
Succinylcholine—Shock—Topiramate—epilepsy syndrome	0.000116	0.000729	CcSEcCtD
Succinylcholine—Tachycardia—Topiramate—epilepsy syndrome	0.000115	0.000724	CcSEcCtD
Succinylcholine—Hypersensitivity—Pregabalin—epilepsy syndrome	0.000113	0.000708	CcSEcCtD
Succinylcholine—Urticaria—Gabapentin—epilepsy syndrome	0.000112	0.0007	CcSEcCtD
Succinylcholine—Body temperature increased—Gabapentin—epilepsy syndrome	0.000111	0.000697	CcSEcCtD
Succinylcholine—Hypotension—Topiramate—epilepsy syndrome	0.000111	0.000693	CcSEcCtD
Succinylcholine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	0.000108	0.000676	CcSEcCtD
Succinylcholine—Rash—Valproic Acid—epilepsy syndrome	0.000107	0.00067	CcSEcCtD
Succinylcholine—Dermatitis—Valproic Acid—epilepsy syndrome	0.000107	0.00067	CcSEcCtD
Succinylcholine—Hypersensitivity—Gabapentin—epilepsy syndrome	0.000104	0.000649	CcSEcCtD
Succinylcholine—Rash—Pregabalin—epilepsy syndrome	9.67e-05	0.000606	CcSEcCtD
Succinylcholine—Dermatitis—Pregabalin—epilepsy syndrome	9.66e-05	0.000605	CcSEcCtD
Succinylcholine—Urticaria—Topiramate—epilepsy syndrome	9.4e-05	0.000589	CcSEcCtD
Succinylcholine—Body temperature increased—Topiramate—epilepsy syndrome	9.35e-05	0.000586	CcSEcCtD
Succinylcholine—Rash—Gabapentin—epilepsy syndrome	8.87e-05	0.000556	CcSEcCtD
Succinylcholine—Dermatitis—Gabapentin—epilepsy syndrome	8.86e-05	0.000555	CcSEcCtD
Succinylcholine—Hypersensitivity—Topiramate—epilepsy syndrome	8.72e-05	0.000546	CcSEcCtD
Succinylcholine—Rash—Topiramate—epilepsy syndrome	7.46e-05	0.000467	CcSEcCtD
Succinylcholine—Dermatitis—Topiramate—epilepsy syndrome	7.45e-05	0.000467	CcSEcCtD
Succinylcholine—CHRM3—Signaling Pathways—CX3CL1—epilepsy syndrome	4.98e-06	2.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—BDKRB1—epilepsy syndrome	4.98e-06	2.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CHRM2—epilepsy syndrome	4.98e-06	2.84e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—BDKRB1—epilepsy syndrome	4.93e-06	2.81e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CX3CL1—epilepsy syndrome	4.93e-06	2.81e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CDC42—epilepsy syndrome	4.88e-06	2.78e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CDC42—epilepsy syndrome	4.86e-06	2.78e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—GABBR1—epilepsy syndrome	4.86e-06	2.77e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—GABBR1—epilepsy syndrome	4.84e-06	2.76e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CDC42—epilepsy syndrome	4.81e-06	2.75e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—GABBR1—epilepsy syndrome	4.79e-06	2.74e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AVP—epilepsy syndrome	4.72e-06	2.7e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AVP—epilepsy syndrome	4.71e-06	2.69e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AVP—epilepsy syndrome	4.66e-06	2.66e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HRH3—epilepsy syndrome	4.65e-06	2.66e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HRH3—epilepsy syndrome	4.64e-06	2.65e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HRH3—epilepsy syndrome	4.59e-06	2.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—OPRM1—epilepsy syndrome	4.58e-06	2.62e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—OPRM1—epilepsy syndrome	4.57e-06	2.61e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—OPRM1—epilepsy syndrome	4.52e-06	2.58e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CYP2D6—epilepsy syndrome	4.51e-06	2.58e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—CCR5—epilepsy syndrome	4.42e-06	2.52e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—CCR5—epilepsy syndrome	4.41e-06	2.52e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—CCR5—epilepsy syndrome	4.36e-06	2.49e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—HMOX1—epilepsy syndrome	4.36e-06	2.49e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR3—epilepsy syndrome	4.33e-06	2.47e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—HTR2A—epilepsy syndrome	4.33e-06	2.47e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR3—epilepsy syndrome	4.31e-06	2.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—HTR2A—epilepsy syndrome	4.31e-06	2.46e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—CAT—epilepsy syndrome	4.3e-06	2.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ADRA2A—epilepsy syndrome	4.29e-06	2.45e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—BCHE—epilepsy syndrome	4.27e-06	2.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR3—epilepsy syndrome	4.27e-06	2.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—HTR2A—epilepsy syndrome	4.27e-06	2.44e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NPY—epilepsy syndrome	4.22e-06	2.41e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ATP2A2—epilepsy syndrome	4.22e-06	2.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NPY—epilepsy syndrome	4.2e-06	2.4e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ATP2A2—epilepsy syndrome	4.2e-06	2.4e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ABCB1—epilepsy syndrome	4.19e-06	2.39e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ATP2A2—epilepsy syndrome	4.16e-06	2.38e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NPY—epilepsy syndrome	4.16e-06	2.38e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AGT—epilepsy syndrome	4.1e-06	2.34e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AGT—epilepsy syndrome	4.09e-06	2.34e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—SLC2A1—epilepsy syndrome	4.08e-06	2.33e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HSPB1—epilepsy syndrome	4.07e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL3—epilepsy syndrome	4.07e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—OXT—epilepsy syndrome	4.07e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CRH—epilepsy syndrome	4.07e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL2—epilepsy syndrome	4.07e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—OXT—epilepsy syndrome	4.06e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HSPB1—epilepsy syndrome	4.06e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL2—epilepsy syndrome	4.06e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL3—epilepsy syndrome	4.06e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CRH—epilepsy syndrome	4.06e-06	2.32e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AGT—epilepsy syndrome	4.05e-06	2.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PLCB1—epilepsy syndrome	4.03e-06	2.3e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—TH—epilepsy syndrome	4.02e-06	2.3e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HSPB1—epilepsy syndrome	4.02e-06	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL2—epilepsy syndrome	4.02e-06	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—OXT—epilepsy syndrome	4.02e-06	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL3—epilepsy syndrome	4.02e-06	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CRH—epilepsy syndrome	4.02e-06	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCR5—epilepsy syndrome	4.01e-06	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCR5—epilepsy syndrome	4e-06	2.29e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCR5—epilepsy syndrome	3.96e-06	2.26e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—HTR2A—epilepsy syndrome	3.93e-06	2.24e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—HTR2A—epilepsy syndrome	3.92e-06	2.24e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—GPX1—epilepsy syndrome	3.89e-06	2.22e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—HTR2A—epilepsy syndrome	3.88e-06	2.21e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.79e-06	2.17e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TSC1—epilepsy syndrome	3.78e-06	2.16e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PTK2B—epilepsy syndrome	3.78e-06	2.16e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.78e-06	2.16e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TSC1—epilepsy syndrome	3.77e-06	2.15e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PTK2B—epilepsy syndrome	3.77e-06	2.15e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—PRKCB—epilepsy syndrome	3.74e-06	2.14e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TSC1—epilepsy syndrome	3.73e-06	2.13e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PTK2B—epilepsy syndrome	3.73e-06	2.13e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AGT—epilepsy syndrome	3.73e-06	2.13e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AGT—epilepsy syndrome	3.71e-06	2.12e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NTRK2—epilepsy syndrome	3.68e-06	2.1e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR2—epilepsy syndrome	3.68e-06	2.1e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SST—epilepsy syndrome	3.68e-06	2.1e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AGT—epilepsy syndrome	3.68e-06	2.1e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NTRK2—epilepsy syndrome	3.67e-06	2.09e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SST—epilepsy syndrome	3.67e-06	2.09e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR2—epilepsy syndrome	3.67e-06	2.09e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—DUSP6—epilepsy syndrome	3.65e-06	2.08e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—DUSP6—epilepsy syndrome	3.64e-06	2.08e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR2—epilepsy syndrome	3.63e-06	2.07e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NTRK2—epilepsy syndrome	3.63e-06	2.07e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SST—epilepsy syndrome	3.63e-06	2.07e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADRA2A—epilepsy syndrome	3.6e-06	2.06e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—DUSP6—epilepsy syndrome	3.6e-06	2.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADRA2A—epilepsy syndrome	3.59e-06	2.05e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PLAT—epilepsy syndrome	3.59e-06	2.05e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PLAT—epilepsy syndrome	3.57e-06	2.04e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADRA2A—epilepsy syndrome	3.55e-06	2.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PLAT—epilepsy syndrome	3.54e-06	2.02e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—BDKRB2—epilepsy syndrome	3.46e-06	1.98e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CXCL12—epilepsy syndrome	3.46e-06	1.98e-05	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—POMC—epilepsy syndrome	3.45e-06	1.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—BDKRB2—epilepsy syndrome	3.45e-06	1.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CXCL12—epilepsy syndrome	3.45e-06	1.97e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—PRKCB—epilepsy syndrome	3.44e-06	1.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—POMC—epilepsy syndrome	3.44e-06	1.97e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—PRKCB—epilepsy syndrome	3.43e-06	1.96e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—IL6ST—epilepsy syndrome	3.43e-06	1.96e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—IL6ST—epilepsy syndrome	3.42e-06	1.95e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CXCL12—epilepsy syndrome	3.41e-06	1.95e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—BDKRB2—epilepsy syndrome	3.41e-06	1.95e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AGT—epilepsy syndrome	3.41e-06	1.95e-05	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—POMC—epilepsy syndrome	3.41e-06	1.95e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—PRKCB—epilepsy syndrome	3.4e-06	1.94e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JUNB—epilepsy syndrome	3.4e-06	1.94e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CNR1—epilepsy syndrome	3.4e-06	1.94e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—IL6ST—epilepsy syndrome	3.39e-06	1.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CNR1—epilepsy syndrome	3.38e-06	1.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JUNB—epilepsy syndrome	3.38e-06	1.93e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PLCB1—epilepsy syndrome	3.38e-06	1.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PLCB1—epilepsy syndrome	3.37e-06	1.93e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—HMOX1—epilepsy syndrome	3.35e-06	1.92e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JUNB—epilepsy syndrome	3.35e-06	1.91e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CNR1—epilepsy syndrome	3.35e-06	1.91e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—APOE—epilepsy syndrome	3.34e-06	1.91e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PLCB1—epilepsy syndrome	3.34e-06	1.91e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HTR7—epilepsy syndrome	3.31e-06	1.89e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—CAT—epilepsy syndrome	3.31e-06	1.89e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HTR7—epilepsy syndrome	3.3e-06	1.89e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HTR7—epilepsy syndrome	3.27e-06	1.87e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ABCB1—epilepsy syndrome	3.22e-06	1.84e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HBEGF—epilepsy syndrome	3.22e-06	1.84e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HBEGF—epilepsy syndrome	3.21e-06	1.83e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HBEGF—epilepsy syndrome	3.17e-06	1.81e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT3—epilepsy syndrome	3.16e-06	1.8e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT3—epilepsy syndrome	3.15e-06	1.8e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—POMC—epilepsy syndrome	3.14e-06	1.79e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—POMC—epilepsy syndrome	3.13e-06	1.79e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT3—epilepsy syndrome	3.12e-06	1.78e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—POMC—epilepsy syndrome	3.1e-06	1.77e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—ADAM10—epilepsy syndrome	3.08e-06	1.76e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—ADAM10—epilepsy syndrome	3.07e-06	1.76e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—CCL2—epilepsy syndrome	3.07e-06	1.75e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—CCL2—epilepsy syndrome	3.06e-06	1.75e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—ADAM10—epilepsy syndrome	3.04e-06	1.74e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—CCL2—epilepsy syndrome	3.03e-06	1.73e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—GPX1—epilepsy syndrome	2.99e-06	1.71e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—S100B—epilepsy syndrome	2.92e-06	1.67e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—S100B—epilepsy syndrome	2.91e-06	1.66e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SOCS3—epilepsy syndrome	2.89e-06	1.65e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CDC42—epilepsy syndrome	2.88e-06	1.65e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—S100B—epilepsy syndrome	2.88e-06	1.64e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SOCS3—epilepsy syndrome	2.88e-06	1.64e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—POMC—epilepsy syndrome	2.87e-06	1.64e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CDC42—epilepsy syndrome	2.87e-06	1.64e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SOCS3—epilepsy syndrome	2.85e-06	1.63e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CDC42—epilepsy syndrome	2.84e-06	1.62e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AVP—epilepsy syndrome	2.79e-06	1.59e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AVP—epilepsy syndrome	2.78e-06	1.59e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AVP—epilepsy syndrome	2.75e-06	1.57e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HES1—epilepsy syndrome	2.64e-06	1.51e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HES1—epilepsy syndrome	2.63e-06	1.5e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AGT—epilepsy syndrome	2.62e-06	1.5e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—ALB—epilepsy syndrome	2.62e-06	1.5e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HES1—epilepsy syndrome	2.6e-06	1.49e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—APOE—epilepsy syndrome	2.57e-06	1.47e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	2.56e-06	1.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	2.56e-06	1.46e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	2.55e-06	1.46e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	2.55e-06	1.46e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	2.55e-06	1.45e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	2.54e-06	1.45e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	2.53e-06	1.45e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	2.52e-06	1.44e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	2.52e-06	1.44e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	2.46e-06	1.41e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	2.46e-06	1.4e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	2.44e-06	1.39e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.43e-06	1.39e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	2.43e-06	1.39e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	2.41e-06	1.37e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	2.37e-06	1.35e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	2.36e-06	1.35e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	2.34e-06	1.34e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	2.32e-06	1.33e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	2.31e-06	1.32e-05	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—PTGS2—epilepsy syndrome	2.29e-06	1.31e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	2.29e-06	1.31e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—POMC—epilepsy syndrome	2.21e-06	1.26e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	2.2e-06	1.26e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	2.2e-06	1.26e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	2.2e-06	1.25e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	2.19e-06	1.25e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	2.18e-06	1.24e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	2.17e-06	1.24e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	2.16e-06	1.23e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	2.15e-06	1.23e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	2.13e-06	1.22e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	2.11e-06	1.21e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	2.11e-06	1.2e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	2.09e-06	1.19e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	2.03e-06	1.16e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	2.03e-06	1.16e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	2.03e-06	1.16e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	2.02e-06	1.15e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—ALB—epilepsy syndrome	2.01e-06	1.15e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	2.01e-06	1.15e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	2e-06	1.14e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	1.85e-06	1.06e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	1.85e-06	1.05e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	1.83e-06	1.04e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	1.81e-06	1.04e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	1.81e-06	1.03e-05	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	1.79e-06	1.02e-05	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—PTGS2—epilepsy syndrome	1.76e-06	1.01e-05	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	1.64e-06	9.36e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	1.63e-06	9.33e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	1.62e-06	9.24e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	1.52e-06	8.69e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	1.52e-06	8.66e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	1.5e-06	8.58e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	1.49e-06	8.52e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	1.49e-06	8.49e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	1.47e-06	8.41e-06	CbGpPWpGaD
Succinylcholine—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.38e-06	7.91e-06	CbGpPWpGaD
Succinylcholine—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.38e-06	7.88e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	1.37e-06	7.84e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	1.37e-06	7.81e-06	CbGpPWpGaD
Succinylcholine—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.37e-06	7.81e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	1.35e-06	7.74e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	1.33e-06	7.61e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	1.33e-06	7.59e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	1.32e-06	7.51e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	1.3e-06	7.41e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	1.29e-06	7.38e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	1.28e-06	7.31e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	1.26e-06	7.18e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	1.25e-06	7.16e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	1.24e-06	7.09e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	1.2e-06	6.83e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	1.19e-06	6.81e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	1.18e-06	6.74e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	1.16e-06	6.65e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	1.16e-06	6.63e-06	CbGpPWpGaD
Succinylcholine—BCHE—Metabolism—AKT1—epilepsy syndrome	1.15e-06	6.58e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	1.15e-06	6.56e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Metabolism—AKT1—epilepsy syndrome	8.86e-07	5.06e-06	CbGpPWpGaD
Succinylcholine—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	7.43e-07	4.24e-06	CbGpPWpGaD
Succinylcholine—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	7.4e-07	4.23e-06	CbGpPWpGaD
Succinylcholine—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	7.33e-07	4.19e-06	CbGpPWpGaD
